[1] BURGMAIER M, LIBERMAN A, MOLLMANN J, et al. Glucagon-like peptide-1(GLP-1)and its split products GLP-1(9-37)and GLP-1(28-37)stabilize atherosclerotic lesions in apoe/mice[J]. Atherosclerosis, 2013, 231: 427-435. DOI: 10.1016/j.atherosclerosis.2013.08.033. [2] WEI Y, MOJSOV S. Distribution of GLP-1 and PACAP receptors in human tissues[J]. Acta Physiol Scand, 1996, 157: 355-357. DOI:10.1046/j.1365-201X.1996.42256000.x. [3] 朱秋霄.利拉鲁肽对高糖条件下SD乳鼠心肌细胞P38MAPK信号通路作用的研究[D]. 石家庄:河北医科大学,2014:4-10. [4] 杨胜利, 何作云, 冯兵, 等. 缺氧/复氧诱导培养人肥大心肌细胞凋亡模型的建立[J]. 重庆医学, 2004, 33(1):4-6. DOI: 10.3969/j.issn.1671-8348.2004.01.002. [5] 谢琼慧, 赵超莉, 叶子青, 等.微小RNA-21对缺血缺氧大鼠心肌细胞凋亡的影响[J]. 中华烧伤杂志, 2014, 30(2):153-157.DOI: 10.3760/cma.j.issn.1009-2587.2014.02.014. [6] NIKOLAIDIS L A, MANKAD S, SOKOS G G, et al. Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion[J]. Circulation, 2004, 109(8):962-965. DOI: 10.1161/01.CIR.0000120505.91348.58. [7] READ P A, KHAN F Z, DUTKA D P. Cardioprotection against ischemia induced by dobutamine stress using glucagon-like peptide-1 in patients with coronary artery disease[J]. Heart, 2012, 98(5): 408-413. DOI: 10.1136/hrt.2010.219345. [8] NOYAN-ASHRAF M H, MOMEN M A, BAN K, et al. GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes af-ter experimental myocardial infarction in mice[J]. Diabetes, 2009, 58: 975-983. DOI: 10.2337/db08-1193. [9] BATCHULUUN B, INOGUCHI T, SONODA, et al. Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells[J]. Atherosclerosis, 2014, 232: 156-164. DOI: 10.1016/j.atherosclerosis.2013.10.025. [10] CHEN Y T, TSAI T H, YANG C C, et al. Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction[J]. J Transl Med, 2013, 11: 270. DOI: 10.1186/1479-5876-11-270. [11] CHANG G, ZHANG D, YU H, et al. Cardioprotective effects of exenatide against oxidative stress-induced injury[J]. Int J Mol Med, 2013, 32: 1011-1020. DOI: 10.3892/ijmm.2013.1475. [12] SHIRAKI A1, OYAMA J, KOMODA H, et al. The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells[J]. Atherosclerosis, 2012, 221(2): 375-382. DOI: 10.1016/j.atherosclerosis.2011.12.039. [13] 陈旻, 明腾.心肌缺血再灌注损伤机制的研究进展[J]. 山东医药, 2014, 54(41): 98-100.DOI: 10.3969/j.issn.1002-266X.2014.41.040. [14] 张丽娜,吴星恒. 心肌细胞凋亡与PI3K/Akt信号途径表达及其调控机制的研究[J].南昌大学学报(医学版),2010,50(5):119-121. [15] 张金梁.游泳训练改善心梗造成的心肌氧化应激:激活PI3K-akt信号级联的核心作用[J]. 山东体育学院学报,2012, 28(5):62-67.DOI:10.3969/j.issn.1006-2076.2012.05.013. [16] 郭敏,李世平,张彤哲,等.缬沙坦通过PI3K/Akt/eNOS通路保护2型糖尿病大鼠主动脉内皮细胞免受氧化损伤的研究[J].中国医药导报,2016,13(19):18-21. [17] BOSE A K, MOCANU M M, CARR R D, et al. Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury[J]. Diabetes, 2005,54(1):146-151. DOI: 10.2337/diabetes.54.1.146. |